Biomedical subjects

W Pan

Publications and source records attributed to W Pan.

147 records · Page 9Linked to original sources

PubMedDate not supplied

Time of symptom onset of eight common medical emergencies.

Specific time periods of the day may be associated with different frequencies of symptom onset in different diseases. The purpose of the current study was to examine times of symptom onset in eight commonly encountered emergent conditions--cerebral infarction, cerebral hemorrhage, transient ischemic attacks, cardiac dysrhythmias, angina pectoris, acute myocardial infarction, gastrointestinal bleeding, and acute asthma. Data from 4554 cases were retrospectively reviewed. Symptom onset frequency curve diagrams were derived, illustrating peak hours of symptom presentation for each of the eight emergent conditions. Hormonal and metabolic factors that may be related to diurnal variations in symptom onset of the eight diseases are briefly discussed.

Acute Disease↗

PubMedDate not supplied

Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

A potent, long-lasting form of interferon alpha-2a mono-pegylated with a 40 kilodalton branched poly(ethylene glycol) was designed, synthesized, and characterized. Mono-pegylated interferon alpha-2a was comprised of four major positional isomers involving Lys31, Lys121, Lys131, and Lys134 of interferon. The in vitro anti-viral activity of pegylated interferon alpha-2a was found to be only 7% of the original activity. In contrast, the in vivo antitumor activity was severalfold enhanced compared to interferon alpha-2a. Pegylated interferon alpha-2a showed no immunogenicity in mice. After subcutaneous injection of pegylated interferon alpha-2a, a 70-fold increase in serum half-life and a 50-fold increase in mean plasma residence time concomitant with sustained serum concentrations were observed relative to interferon alpha-2a. These preclinical results suggest a significantly enhanced human pharmacological profile for pegylated interferon alpha-2a. Results of Phase II/III hepatitis C clinical trials in humans confirmed the superior efficacy of pegylated interferon alpha-2a compared to unmodified interferon alpha-2a.

Animals↗

PubMedDate not supplied

Inhalable dust exposures, tasks, and use of ventilation in small woodworking shops: a pilot study.

Measures of workers' inhalable dust exposures, tasks, and ventilation use were made in five small woodworking shops prior to the start of an intervention effectiveness study aimed at lowering personal wood dust exposures. The data were used to (1) design a sampling protocol for an intervention success measure, (2) identify targets for intervention among the tasks and activities responsible for high dust levels, and (3) develop shop-level measures as tools for tailoring intervention activities. Geometric mean dust concentrations ranged from 1.6 to 9.9 mg/m3 in the five shops, with the highest levels occurring in a cabinet shop. All shops had centralized dust collection systems and workers generally used dust control on stationary tools (60-100% of the time) when it was available. Sanding with both stationary and handheld powered tools, cleaning with methods that can disperse dust (e.g., brushes, compressed air), and miscellaneous tasks were all responsible for significant personal exposures. The positive association between miscellaneous tasks and exposures probably reflects the high background levels generated by nearby processes. Sanding with both stationary tools and handheld powered tools represents the most significant influence on personal exposures in small woodworking shops. The authors conclude that pilot studies are useful tools for designing occupational health and safety intervention effectiveness studies.

Dust↗